Breakthrough in Understanding Bacteria Could Lead to Chlamydia Vaccine
細菌研究取得突破，有望研發出衣原體疫苗
更新於: 2026年6月11日 上午01:00
For decades, scientists have struggled to create a vaccine for Chlamydia, the world's most common bacterial sexually transmitted infection.
數十年來，科學家們一直致力於研發披衣菌疫苗，這是全球最常見的細菌性性傳播感染。
Now, two major breakthroughs are offering new hope.
如今，兩項重大突破帶來了新的希望。
First, researchers at UT Southwestern Medical Center have used cryo-electron microscopy to map the 3D structure of the Major Outer Membrane Protein (MOMP).
首先，德州大學西南醫學中心的研究人員利用低溫電子顯微鏡（Cryo-electron microscopy），繪製出了主要外膜蛋白（MOMP）的3D結構。
By finally seeing this protein's complex architecture—a three-barrel structure topped with an antigenic cap—scientists can design vaccines that mimic its natural state, which previous attempts failed to achieve.
透過終於能觀察到這種蛋白質複雜的構造——一個頂部帶有抗原蓋（Antigenic cap）的三筒狀結構——科學家們能夠設計出模仿其自然狀態的疫苗，這是先前嘗試所未能達成的。
Because Chlamydia often presents no symptoms and can cause long-term health issues like infertility and chronic pain, these advancements are critical.
由於披衣菌感染通常沒有症狀，且可能導致不孕和慢性疼痛等長期健康問題，這些進展至關重要。
By pairing a precise understanding of the bacteria's physical structure with a more effective way to activate the immune system, the medical community is moving closer to a viable human vaccine, potentially changing the landscape of public health for millions.
藉由將對細菌物理結構的精確理解與更有效的免疫系統活化方式相結合，醫學界正逐漸接近研發出可行的疫苗，這有望改變數百萬人的公共衛生前景。
